Managed Care - January 2009 - (Page 43)

THE FORMULARY FILES E-prescribing system increases generic usage Introducing electronic prescribing systems and coupling them to formulary decision support (FDS) systems allows clinicians to prescribe preferred medications more frequently, according to a study involving two large Massachusetts insurers. Researchers at Brigham & Women’s Hospital found that those who used e-prescribing showed a 3.3 percent increase in prescribing tier 1 (generic) medications. The researchers also reported a corresponding decrease in the proportion of prescriptions from tiers 2 and 3 (brand names). For physicians who adopted e-prescribing systems, 20 percent of the prescriptions were electronic. The researchers estimate that e-prescribing with FDS at this rate could save $845,000 per 100,000 patients. The researchers tested the savings potential before and after an e-prescribing system was launched, calculating the proportion of prescriptions written in each of three formulary tiers. Tier 1 medications required the lowest copayments and were all generic medications. “Among the physicians who used e-prescribing, we saw these changes in tier 1 generic prescribing. When they didn’t use e-prescribing, they stayed on the same trend line as everyone else,” says Michael Fischer, MD, MS, the lead author. “Our results suggest that if an insurer can find a way to get doctors the formulary information in a way that doesn’t interfere with their workflow, and in a timely manner, even in a state where there is a lot of generic drug use, doctors will act on it,” says Fischer. Physicians who wrote electronic prescriptions were slightly younger and more likely to be female than those who did not. In addition, internists, pediatricians, and family physicians made up nearly 75 percent of those who used e-prescribing. The study is published in the Dec. 8 issue of Archives of Internal Medicine. Predicted prescribing by formulary tier The intervention group prescribed 1.4 percent more tier 1 medications, 0.3 percent fewer tier 2 medications, and 1 percent fewer tier 3 medications than the control group. Formulary tier Prescriptions before system was installed After system was installed: Nonelectronic prescriptions Electronic prescriptions 3.3% Differences 1.4% 56.3% 59.7% 34.1% 32.3% Nonelectronic prescriptions vs. baseline Nonelectronic prescriptions vs. electronic Tier 1 Tier 2 55.0% Tier 3 35.4% 10.5% 9.5% 8.0% –0.3% Tier 1 –1.9% Tier 2 –1.0% –1.5% Tier 3 JANUARY 2009 / MANAGED CARE 43

Table of Contents Feed for the Digital Edition of Managed Care - January 2009

Managed Care - January 2009 Editor's Memo Contents Legislation & Regulation News and Commentary Medication Management Compensation Monitor Health Care's Disruptive Innovations Q&A With Clayton Christensen 'Disruption' May Be Plans' Best Bet Avoid the PBM Rebate Trap HealthPartners Puts Diabetes on Notice Formulary Files Plan Watch Tomorrow's Medicine Ad Index Outlook Unmet Needs in the Management of Plaque Psoriasis Impact of RSV: Implications for Managed Care

Managed Care - January 2009

For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.